Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 358 Carcinoma, Non-Small-Cell Lung 178 Neoplasms 109 Breast Neoplasms 97 Lung Neoplasms 81 Urinary Bladder Neoplasms 79 Neoplasm Metastasis 74 Ovarian Neoplasms 53 Cholangiocarcinoma 39 Sarcoma 38 Lymphoma 38 Biliary Tract Neoplasms 35 Gallbladder Neoplasms 34 Hodgkin Disease 30 Lymphoma, Non-Hodgkin 27 Adenocarcinoma 27 Lymphoma, Large B-Cell, Diffuse 25 Colorectal Neoplasms 24 Bile Duct Neoplasms 23 Triple Negative Breast Neoplasms 22 Recurrence 22 Fallopian Tube Neoplasms 22 Unspecified Adult Solid Tumor, Protocol Specific 21 Carcinoma, Transitional Cell 21 Carcinoma, Ovarian Epithelial 21 Urethral Neoplasms 20 Carcinoma 17 Adenocarcinoma of Lung 15 Head and Neck Neoplasms 14 Carcinoma, Renal Cell 14

Interventions

Fulvestrant 5 Anastrozole 4 Letrozole 3 Docetaxel 2 Dasatinib 2 vandetanib 1 sonidegib 1 ribociclib 1 pembrolizumab 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 exemestane 1 cediranib 1 XMT-1522 1 Vorinostat 1 Tablets 1 Ritonavir 1 Population Groups 1 Paclitaxel 1 Moxifloxacin 1 Itraconazole 1 Histone Deacetylase Inhibitors 1 Gemcitabine 1 FCN-437c 1 Everolimus 1 Electroporation 1 Cryosurgery 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Breast Cancer × Gemcitabine × Clear all

NCT03025880 2023-04-03

PANGEA

Spanish Breast Cancer Research Group

Phase 2 Completed

36 enrolled 28 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡